Detalles de la búsqueda
1.
A Feshbach resonance in collisions between triplet ground-state molecules.
Nature;
614(7946): 54-58, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36725997
2.
Collisional cooling of ultracold molecules.
Nature;
580(7802): 197-200, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32269350
3.
Two-photon spectroscopy of the NaLi triplet ground state.
Phys Chem Chem Phys;
20(7): 4739-4745, 2018 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29379932
4.
Photoassociation of ultracold NaLi.
Phys Chem Chem Phys;
20(7): 4746-4751, 2018 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29380828
5.
Long-Lived Ultracold Molecules with Electric and Magnetic Dipole Moments.
Phys Rev Lett;
119(14): 143001, 2017 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29053331
6.
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study.
EClinicalMedicine;
62: 102109, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37533419
7.
Control of reactive collisions by quantum interference.
Science;
375(6584): 1006-1010, 2022 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35239387
8.
Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies.
Hum Vaccin Immunother;
18(6): 2132798, 2022 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36328438
9.
Immunogenicity and safety of booster CYD-TDV dengue vaccine after alternative primary vaccination schedules in healthy individuals aged 9-50 years: a randomised, controlled, phase 2, non-inferiority study.
Lancet Infect Dis;
22(6): 901-911, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35364022
10.
Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore: 2-year follow-up of a randomized phase II, placebo-controlled trial.
Hum Vaccin Immunother;
17(7): 2107-2116, 2021 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33626291
11.
Immunogenicity and safety of simplified vaccination schedules for the CYD-TDV dengue vaccine in healthy individuals aged 9-50 years (CYD65): a randomised, controlled, phase 2, non-inferiority study.
Lancet Infect Dis;
21(4): 517-528, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33212067
12.
Immunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebo-controlled trial evaluating its effects 5-6 years after completion of the primary series.
Hum Vaccin Immunother;
16(3): 523-529, 2020 03 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31464558
Resultados
1 -
12
de 12
1
Próxima >
>>